emerging tech investing Sona Nanotech To Hold Investor Webinar To Discuss Follow-up Data From First-in-human Cancer Therapy Study
emerging tech investing Sona Nanotech Reports 80% Response Rate in First-In-Human THT Cancer Therapy Study
